Psychoeducation for Transient Ischaemic Attack and Minor Stroke
NCT ID: NCT02550392
Last Updated: 2020-03-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
64 participants
INTERVENTIONAL
2016-03-31
2020-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study aims to develop, tailor and target the delivery of a time-limited group intervention that offers educational, psychological and social support for people following TIA and minor stroke. A qualitative study (Phase 1) will be conducted with service users and experts working with people with TIA/minor stroke to develop the psychoeducational intervention. Following this, we will conduct a feasibility randomised controlled trial in one centre (Phase 2) to explore whether this group psychoeducational intervention for people after TIA and minor stroke carers is acceptable and to determine the feasibility of the proposed evaluation and the sample size needed in a definite trial.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early-phase Telecare Programs for Minor Stroke
NCT06306144
Cognitive Changes and Rehabilitation in People With Transient Ischemic Attack, Stroke, or Stroke Risk Factors
NCT01951612
Tailored Interventions to Improve Hypertension Management After Stroke or Transient Ischemic Attack (TIA)
NCT01038375
Working Memory Training in Older Adults With Mild Cognitive Impairment : Impacts on Cognition and Ecological Activities
NCT04606953
Guided Training for People With Cognitive Impairment
NCT03225768
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group psychoeducation
The intervention group will receive a group psychoeducational intervention (designed in Phase 1: Qualitative study) and usual care.
Psychoeducation
A time-limited group psychoeducational intervention that will aim to offer educational, psychological and social support.
Control group
Participants in the usual care control group will continue to receive all other services routinely available to them as is usual practice.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Psychoeducation
A time-limited group psychoeducational intervention that will aim to offer educational, psychological and social support.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* identified within 6 months of their diagnosis;
* who are independent with activities of daily living;
* who consent to take part
Exclusion Criteria
* receiving psychological interventions for mental health difficulties immediately prior to their TIA/minor stroke, visual or hearing impairments that would impact on ability to complete baseline assessments;
* cognitive or communication difficulties that would impact on ability to complete baseline assessments and to participate in group sessions;
* unable to communicate in English.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Stroke Association, United Kingdom
OTHER
Nottingham University Hospitals NHS Trust
OTHER
University of Nottingham
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eirini Kontou, PhD DClinPsy
Role: PRINCIPAL_INVESTIGATOR
University of Nottingham
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nottingham University Hospitals NHS Trust
Nottingham, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TSA PDF 2015-01
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
15079
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.